arrow
J

Javad Nouri Hajari

Rigshospitalet
H指数:12
被引数:591

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative efficacy of intravitreal anti-VEGF therapy for neovascular age-related macular degeneration: A systematic review with network meta-analysis

比较抗VEGF玻璃体内注射治疗新生血管性年龄相关性黄斑变性的疗效:一项系统评价和网络Meta分析

2025-04-170
PRE
Novel Blood-Biomarkers to Detect Retinal Neurodegeneration and Inflammation in Diabetic Retinopathy

新型血液生物标志物用于检测糖尿病视网膜病变中的视网膜神经退行性变和炎症

2025-03-140
OA
Treatment Interval Progression and Adherence to Observe-and-Plan Regimen for Neovascular Age-Related Macular Degeneration Treated with Aflibercept 2 mg

治疗间隔进展及对观察-计划方案(Observe-and-Plan Regimen)的依从性:接受阿柏西普(Aflibercept)2 mg治疗的病理性近视黄斑变性患者

2025-02-031
OA
Efficacy of intravitreal faricimab therapy for polypoidal choroidal vasculopathy: A systematic review and meta-analysis

玻璃体腔注射faricimab治疗息肉状脉络膜血管病变疗效的系统评价和meta分析

2024-11-161
OA
Presence and development of diabetic retinopathy in 16 999 patients with type 1 diabetes in the Danish Registry of Diabetic Retinopathy

丹麦糖尿病性视网膜病登记中16名999 1型糖尿病患者的糖尿病性视网膜病变的存在和发展

2024-05-181
OA
Risk of Diabetic Retinopathy According to Subtype of Type 2 Diabetes

根据2型糖尿病的亚型,糖尿病视网膜病变的风险

2024-03-181
OAAI
Diabetic retinopathy as an independent marker of cardiovascular disease in type 1 diabetes: Results from a nationwide longitudinal matched case-cohort study

糖尿病性视网膜病变作为1型糖尿病心血管疾病的独立标志物: 来自全国纵向匹配病例队列研究的结果

2024-02-121
OA
Five-Year Incidence of Proliferative Diabetic Retinopathy and Associated Risk Factors in a Nationwide Cohort of 201 945 Danish Patients with Diabetes
2023-09-018
OAAI